respiratory system
• pups nursing on dams administered doxycycline from P1 to P14 exhibit decreased capillary formation in alveolar septa
|
• pups nursing on dams administered doxycycline from P1 to P14 exhibit disrupted alveolarization, showing a 27% and 31% decrease in the mean alveolar airspace area and mean cord length, respectively
• pups nursing on dams administered doxycycline from P1 to P14 exhibit disorganized elastic fiber deposition on alveolar surfaces and in septa
|
• pups nursing on dams administered doxycycline from P1 to P14 exhibit a 34% decrease in secondary septa
• marker analysis indicates that pups nursing on dams administered doxycycline from P1 to P14 exhibit increased myofibroblast differentiation in alveolar septa
• pups nursing on dams administered doxycycline from P1 to P14 exhibit a 48% increase in the proliferating cell index in alveolar septa
• pups nursing on dams administered doxycycline from P1 to P14 exhibit decreased capillary formation in alveolar septa
|
• pups nursing on dams administered doxycycline from P1 to P14 exhibit thickening in the peribronchial/peribronchiolar and perivascular regions of the lungs and increased collagen deposition in these regions, indicating fibrosis
|
cardiovascular system
• pups nursing on dams administered doxycycline from P1 to P14 exhibit decreased capillary formation in alveolar septa
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
lower respiratory tract disease | DOID:0050161 | J:171488 |